|Day's range||0.385 - 0.390|
|52-week range||0.230 - 0.500|
|PE ratio (TTM)||-11.00|
|Earnings date||16 Aug. 2016 - 20 Aug. 2016|
|Dividend & yield||N/A (N/A)|
|1y target est||1.46|
ASX ANNOUNCEMENT 8 November 2016 ABN 53 075 582 740 2016 has been an eventful year as we sought to advance our drug pipeline, strengthen your Company's balance sheet, further globalise the share register, ...
7 October 2016 Dear Shareholder ANNUAL GENERAL MEETING I am pleased to invite you to attend the Annual General Meeting of Bionomics Limited, to be held at Crowne Plaza Adelaide, Level 15 Hindmarsh Rooms ...
ASX ANNOUNCEMENT 22 September 2016 ABN 53 075 582 740 Bionomics Limited (ASX:BNO, OTCQX:BNOEF), a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment ...